See more : Padmalaya Telefilms Limited (PADMALAYAT.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Reliance Chemotex Industries Limited (RELCHEMQ.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Reliance Chemotex Industries Limited, a leading company in the Apparel – Manufacturers industry within the Consumer Cyclical sector.
You may be interested
- Restaurant Brands New Zealand Limited (RBD.NZ) Income Statement Analysis – Financial Results
- THC Therapeutics, Inc. (THCT) Income Statement Analysis – Financial Results
- GFL Environmental Inc. (GFL) Income Statement Analysis – Financial Results
- Braveheart Resources Inc. (BHT.V) Income Statement Analysis – Financial Results
- PUMA SE (PUM.DE) Income Statement Analysis – Financial Results
Reliance Chemotex Industries Limited (RELCHEMQ.NS)
About Reliance Chemotex Industries Limited
Reliance Chemotex Industries Limited engages in the manufacture and sale of synthetic and blended yarns in India and internationally. It offers home furnishing, industrial, and apparel yarns. The company also export its products to approximately 37 countries. Reliance Chemotex Industries Limited was incorporated in 1977 and is headquartered in Kolkata, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.67B | 3.65B | 3.47B | 2.49B | 2.88B | 3.15B | 2.69B | 2.67B | 2.57B | 2.35B | 2.50B | 2.04B | 1.99B | 1.90B | 1.63B | 1.25B | 1.33B |
| Cost of Revenue | 3.16B | 2.23B | 1.87B | 1.31B | 1.65B | 1.96B | 1.64B | 1.82B | 1.41B | 1.35B | 1.62B | 1.19B | 1.20B | 1.41B | 1.26B | 821.32M | 991.11M |
| Gross Profit | 507.60M | 1.42B | 1.60B | 1.17B | 1.23B | 1.19B | 1.05B | 847.53M | 1.16B | 995.56M | 882.06M | 850.08M | 796.92M | 492.50M | 366.12M | 428.45M | 337.61M |
| Gross Profit Ratio | 13.82% | 38.89% | 46.18% | 47.18% | 42.84% | 37.79% | 38.96% | 31.79% | 45.25% | 42.45% | 35.29% | 41.61% | 39.98% | 25.88% | 22.46% | 34.28% | 25.41% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.31M | 6.75M | 6.32M | 6.48M | 6.52M | 4.79M | 3.52M | 2.71M | 3.14M | 0.00 | 1.24M | 1.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 268.67M | 360.90M | 414.22M | 216.90M | 126.54M | 113.64M | 57.65M | 76.46M | 0.00 | 0.00 | 110.34M | 104.31M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 274.98M | 367.65M | 420.53M | 223.38M | 133.07M | 118.43M | 61.17M | 79.17M | 3.14M | 323.15M | 375.25M | 313.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 1.29B | 61.59M | 3.96M | 2.43M | 1.99M | 1.55M | 2.71M | 13.24M | 7.72M | 399.43K | 1.98M | 685.39M | 658.22M | 348.56M | 247.69M | 347.87M | 266.98M |
| Operating Expenses | 1.56B | 1.17B | 1.25B | 1.02B | 1.03B | 1.01B | 961.40M | 759.31M | 1.04B | 946.29M | 701.02M | 685.39M | 658.22M | 348.56M | 247.69M | 347.87M | 266.98M |
| Cost & Expenses | 3.45B | 3.40B | 3.12B | 2.33B | 2.68B | 2.97B | 2.60B | 2.58B | 2.45B | 2.30B | 2.32B | 1.88B | 1.85B | 1.76B | 1.51B | 1.17B | 1.26B |
| Interest Income | 38.70M | 30.76M | 26.45M | 12.31M | 6.25M | 7.66M | 9.71M | 14.18M | 18.25M | 24.03M | 24.93M | 9.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 195.65M | 139.32M | 82.19M | 58.21M | 58.68M | 67.91M | 57.48M | 61.47M | 79.72M | 69.34M | 51.37M | 86.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 100.89M | 97.20M | 85.30M | 75.99M | 73.38M | 67.10M | 73.94M | 67.12M | 65.97M | 57.41M | 56.15M | 47.03M | 46.99M | 45.89M | 43.09M | 27.08M | 23.15M |
| EBITDA | 275.83M | 403.59M | 480.30M | 276.09M | 294.41M | 215.37M | 139.56M | 200.25M | 188.17M | 106.66M | 202.10M | 187.85M | 180.01M | 200.56M | 161.52M | 107.66M | 93.78M |
| EBITDA Ratio | 7.51% | 11.07% | 13.56% | 9.68% | 8.25% | 6.78% | 4.96% | 7.72% | 6.30% | 9.10% | 9.72% | 10.55% | 9.89% | 9.98% | 9.91% | 8.61% | 7.06% |
| Operating Income | 209.26M | 255.13M | 377.70M | 159.84M | 240.40M | 188.40M | 87.39M | 68.71M | 9.37M | 89.57M | 92.60M | 77.01M | 29.33M | 51.30M | 31.91M | 29.77M | 31.55M |
| Operating Income Ratio | 5.70% | 6.99% | 10.87% | 6.42% | 8.35% | 5.98% | 3.25% | 2.58% | 0.36% | 3.82% | 3.71% | 3.77% | 1.47% | 2.70% | 1.96% | 2.38% | 2.37% |
| Total Other Income/Expenses | -152.99M | -100.76M | -56.29M | -45.64M | -91.69M | -99.55M | -79.24M | -844.28M | -790.28M | -569.26M | -215.30M | -65.69M | 0.00 | 17.80K | 0.00 | -2.00K | 0.00 |
| Income Before Tax | 56.28M | 167.08M | 273.51M | 103.62M | 107.74M | 80.37M | 8.15M | 78.90M | 17.09M | 90.54M | 94.58M | 77.01M | 29.33M | 51.30M | 31.91M | 29.77M | 31.55M |
| Income Before Tax Ratio | 1.53% | 4.58% | 7.87% | 4.16% | 3.74% | 2.55% | 0.30% | 2.96% | 0.66% | 3.86% | 3.78% | 3.77% | 1.47% | 2.70% | 1.96% | 2.38% | 2.37% |
| Income Tax Expense | 24.18M | 42.88M | 92.19M | 34.31M | 14.43M | 39.45M | -17.91M | 11.92M | -8.22M | 25.44M | 37.99M | 16.66M | 7.10M | 7.32M | 14.06M | 10.98M | 6.11M |
| Net Income | 32.10M | 124.19M | 181.32M | 69.31M | 93.31M | 40.91M | 25.98M | 66.98M | 25.31M | 65.10M | 56.59M | 60.35M | 22.23M | 43.84M | 18.20M | 18.80M | 25.44M |
| Net Income Ratio | 0.87% | 3.40% | 5.22% | 2.79% | 3.24% | 1.30% | 0.97% | 2.51% | 0.98% | 2.78% | 2.26% | 2.95% | 1.12% | 2.30% | 1.12% | 1.50% | 1.91% |
| EPS | 4.26 | 16.46 | 24.04 | 9.19 | 14.68 | 10.28 | 5.82 | 14.52 | -0.55 | 9.01 | 8.05 | 11.07 | 5.49 | 10.83 | 4.49 | 4.51 | 4.15 |
| EPS Diluted | 4.26 | 16.46 | 24.04 | 9.19 | 14.68 | 10.28 | 5.82 | 14.52 | -0.55 | 9.01 | 8.05 | 11.07 | 5.49 | 10.83 | 4.49 | 4.51 | 4.15 |
| Weighted Avg Shares Out | 7.53M | 7.54M | 7.54M | 7.54M | 6.36M | 3.98M | 4.46M | 4.46M | 4.46M | 4.46M | 4.25M | 4.05M | 4.05M | 4.05M | 4.05M | 3.87M | 6.12M |
| Weighted Avg Shares Out (Dil) | 7.54M | 7.54M | 7.54M | 7.54M | 6.36M | 3.98M | 4.46M | 4.46M | 4.46M | 4.46M | 4.25M | 4.05M | 4.05M | 4.05M | 4.05M | 3.87M | 6.12M |
No news found for: RELCHEMQ.NS
Source: https://incomestatements.info
Category: Stock Reports